tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Short Report: Frontier Group short positioning continues gaining altitude
PremiumThe FlyShort Report: Frontier Group short positioning continues gaining altitude
2M ago
Sionna Therapeutics initiated with a Sector Perform at RBC Capital
Premium
The Fly
Sionna Therapeutics initiated with a Sector Perform at RBC Capital
2M ago
Sionna Therapeutics initiated with a Strong Buy at Raymond James
Premium
The Fly
Sionna Therapeutics initiated with a Strong Buy at Raymond James
2M ago
Sionna Therapeutics Reports Positive Phase 1 Trial Results
PremiumCompany AnnouncementsSionna Therapeutics Reports Positive Phase 1 Trial Results
5M ago
Sionna Therapeutics announces data from Phase 1 trials of SION-719, SION-451
Premium
The Fly
Sionna Therapeutics announces data from Phase 1 trials of SION-719, SION-451
5M ago
Sionna Therapeutics reports Q1 EPS (62c), consensus (45c)
Premium
The Fly
Sionna Therapeutics reports Q1 EPS (62c), consensus (45c)
6M ago
Sionna Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlySionna Therapeutics initiated with a Buy at TD Cowen
8M ago
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation
Premium
The Fly
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation
8M ago
Innovative Approach to Cystic Fibrosis Treatment: Sionna Therapeutics’ Pioneering Pipeline Earns Buy Rating
Premium
Ratings
Innovative Approach to Cystic Fibrosis Treatment: Sionna Therapeutics’ Pioneering Pipeline Earns Buy Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100